nancy n. and j.c. lewis cancer & research pavilion skin ......the nancy n. and j.c. lewis cancer...

Nancy N. and J.C. Lewis Cancer & Research Pavilion

SKIN CANCER 2013 REPORT

SELECTED A NATIONAL CANCER INSTITUTE COMMUNITY CANCER CENTER PROGRAM.

2

St. Joseph’s/Candler Mission and Vision

MissionRooted in God’s love, we treat illness and promote wellness for all people.

VisionTo set the standards of excellence in the delivery of healthcare throughout the regions we serve.

Nancy N. and J.C. Lewis Cancer & Research Pavilion and the Oncology Service Line

Mission and Vision

MissionHolistic, multi-disciplinary, patient-centered cancer care provided

across the disease continuum for all stages of a patient’s journey.

VisionTo be the premier destination for comprehensive cancer care

in the region while providing a superior patient experience.

2

3

A Message from the Cancer Committee Chairman

The Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) embraces the highest standards of service, quality, and best practices in care through adherence to the Commission on Cancer and the National Cancer Institute standards and initiatives.

Melanoma is the 5th most common cancer in the United States and its incidence continues to rise. Among young women ages 20 to 30, melanoma is the most common cancer. According to the American Cancer Society’s Cancer Facts and Figures 2013, an estimated 2,360 new melanoma cases were diagnosed in Georgia in 2013 and an estimated 209 individuals in Georgia died of melanoma. Additionally, the lifetime risk of developing melanoma is 23 times higher among whites than among African Americans.

The incidence rate of melanoma in Georgia, at 21.6 cases per 100,000 individuals, is higher than the national rate of 19.0 cases per 100,000. The LCRP is responding to this need. As a regional destination for cancer care, we ensure that all skin cancer patients have access to the most technologically advanced treatment options, nationally recognized evidence-based treatment guidelines, personalized medicine, and access to clinical trials. In addition, we offer supportive oncology services including palliative care, navigation services, nutritional services, support groups, and survivorship care. For example, the LCRP is expanding access to clinical trials for skin cancer patients. From 2011 – 2013, we enrolled a total of 10 skin cancer patients into clinical trials – providing the opportunity for our patients to access the latest and most innovative oncology treatments available. To help advance melanoma cancer treatment and research the LCRP participates in fundraising events such as the annual Fishin’ for Jamie golf and fishing tournament.

Within the LCRP service areas of Bryan, Chatham, Effingham, Screven, and Beaufort counties, melanoma incidence rates are higher than national averages. In line with these higher incidence rates along coastal Georgia and South Carolina, 83.0 % of the skin cancer cases treated at the LCRP in 2012 came from counties within the LCRP primary service area - Bryan, Chatham, Effingham, and Beaufort. To this measure, each year an in-depth cancer site specific analysis of disease and treatment through St. Joseph/ Candler is completed and reviewed by the Cancer Committee.

At the LCRP we are committed to the prevention and early detection of skin cancer. The best prevention for skin cancer is to always use sunscreen and hats when spending time in the sun, avoid the sun during its strongest hours, avoid sunburns, and wear long sleeves or other protective clothing if you know that you must be in the sun. Individuals should never use tanning beds – use of tanning beds is a significant risk factor to the development of skin cancer. Even individuals who take these preventive measures should be sure to regularly visits to their dermatologist for assessment.

Remember the ABCDE warning signs rule to help you recognize changes in skin growths that may be melanoma:

A: Asymmetric. Half of the mole does not match the other half.B: Border irregularity. Mole edges are ragged, notched, or blurred. C: Color. Mole pigmentation is not uniform, with variable degrees of tan, brown, or black.D: Diameter greater than 6 millimeters or about the size of a pencil eraser. E: Elevation above the skin surface.

In coordination with local dermatologists the LCRP offers MoleSafe to conduct surveillance for melanoma survivors. In 2011 and 2012, MoleSafe identified lesions of concern needing further follow-up in 12 % of clients. This service allows local dermatologists an additional personalized surveillance tool to closely monitor changes in skin lesions for melanoma survivors.

4

With a total of 160 cases (95 analytic and 65 non-analytic), skin cancer was the fifth most commonly treated cancer sites at the LCRP in 2012, representing a 57 % increase in the number of cases from 2011 (57 analytic ad 45 non-analytic). 35.5 % of the individuals treated for skin cancer at the LCRP in 2011 – 2012 were age 70 or older. A significant proportion – 38.2 % - were ages 50 – 69 and 17.1 % were individuals ages 30 – 49. Corresponding to higher rates of skin cancer among men than women in Georgia and nationally, from 2011 – 2012 the LCRP treated 104 men and 48 women for skin cancer. With the continual development of the LCRP Pigmented Nevus Center, the LCRP multi-disciplinary treatment team is increasingly treating rarer forms of aggressive skin cancer such as merkel cell carcinoma, skin appendageal tumors, and sebaceous carcinoma.

Individuals faced with a diagnosis of skin cancer can be confident that, by picking the Lewis Cancer and Research Pavilion for their treatment and survivorship surveillance, they will receive holistic, multi-disciplinary, patient-centered care at a regional destination for comprehensive cancer care.

H.A. Zaren, MD, FACS

Medical Director, LCRPCancer Committee ChairmanPrimary Investigator, NCCCPProfessor of Surgery at Georgia Regents University and Distinguished Cancer Scientist

5

2011

2012

2%

2%

7%

4%

2% 6%

90% 87%

LCRP Analytic Skin Cancer Cases by Service Area 2011-2012, LCRP Cancer Registry Data

Outside Service Area Tertiary Secondary Primary

CAMDEN13.8

BRANTLEY*

GLYNN17.8

McINTOSH*

WARE13.6

PIERCE*

WAYNE12.4

APPLING*

TOOMBS11.9 TATTNALL

*

WHEELER*

MONTGOMERY*

TREUTLEN*

JOHNSON*

EMANUEL*

CANDLER* BULLOCH

18.0

EVANS*

JENKINS* SCREVEN

21.5

LONG*

LIBERTY9.4

BRYAN30.4 CHATHAM

20.9

EFFINGHAM25.8

JASPER13.9

BEAUFORT44.3

CLINCH*

ATKINSON*

COFFEE14.0

JEFF DAVIS*

BACON*

CHARLTON*

Community Need

Melanoma is the 5th most common cancer in the United States and its incidence continues to rise.1

The risk of developing melanoma increases with age2 , however melanoma is the most common

cancer in women between 20 and 30 years of age.3

The lifetime risk of developing melanoma is 23 times higher among whites than among African

Americans.4

An estimated 76,690 individuals in the United States were diagnosed with melanoma in 2013. 2,360 of

these individuals were from Georgia.5 54 of these individuals were from Chatham County.6

An estimated 9,480 individuals in the United States died of melanoma in 2013. 209 of these individuals

were from Georgia. 8 of these individuals were from Chatham County.7

Melanoma Incidence in LCRP Primary, Secondary, and Tertiary Service Areas

2012, State Cancer ProfilesIncidence Rate per 100,000 individuals

*Data limited if fewer than 16 cases were reported

6

Throughout this report, statistics referring to national data are reported for melanoma rather than for all skin

cancers while data from the LCRP cancer registry includes all skin cancers treated at the LCRP. Melanoma is

the only skin cancer with reporting requirements to cancer registries, thus national data is not available for

other skin cancers. In actuality, melanoma makes up less than 5 % of all skin cancer cases, however, almost all

deaths from skin cancer come from melanoma.8

Melanoma Death and Incidence Rates per 100,0002012, State Cancer Profiles

DEATH RATE ANNUAL INCIDENCE

Georgia 2.5 21.6

United States 2.7 19.0

Five counties in the LCRP service

area (Bryan, Chatham, Effingham,

Screven, and Beaufort, South

Carolina) have melanoma incidence

rates higher than national averages.

CAMDENCHARLTON

BRANTLEY GLYNN

McINTOSH

WARE

PIERCE

WAYNE

APPLING

TOOMBS

TATTNALL

WHEELER

MONTGOMERY

TREUTLEN

JOHNSON

EMANUEL

CANDLERBULLOCH

EVANS

JENKINS

SCREVEN

LONGLIBERTY

BRYAN

CHATHAM

EFFINGHAM

JASPER

BEAUFORT

CLINCH

ATKINSON

COFFEE

JEFFDAVIS

BACON

7

Early Detection

The American Cancer Society provides the following information about skin cancer early detection in their

publication, Cancer Facts & Figures 2013:

Signs and symptoms: Important warning signs of melanoma include changes in size, shape, or color of

a mole or other skin lesion or the appearance of a new growth on the skin. Changes that progress over a

month or more should be evaluated by a doctor.

Risk factors: Risk factors vary for different types of skin cancer. For melanoma, major risk factors include

a personal or family history of melanoma and the presence of atypical or numerous moles (more than 50).

Other risk factors for all types of skin cancer include sun sensitivity (sunburning easily, difficulty tanning,

natural blond or red hair color); a history of excessive sun exposure, including sunburns; use of tanning

booths; diseases that suppress the immune system; and a past history of skin cancer.

Early detection: The best way to detect skin cancer early is to recognize changes in skin growths, including

the appearance of new growths. The ABCD rule outlines the warning signals of the most common type of

melanoma:

A is for asymmetry (one half of the mole does not match the other half)

B is for border irregularity (the edges are ragged, notched, or blurred)

C is for color (the pigmentation is not uniform, with variable degrees of tan, brown, or black)

D is for diameter greater than 6 millimeters (about the size of a pencil eraser).

Other types of melanoma may not have these signs, so be alert for any new or changing skin growths.

Adults should periodically examine their skin and be aware of any changes. New or unusual lesions or a

progressive change in a

lesion’s appearance (size,

shape, or color, etc.) should

be evaluated promptly by

a physician.9 The LCRP

encourages all individuals to

make regular visits to their

dermatologist for assessment.

8

MoleSafe: A New Form of Skin Protection

The Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) is one of nine

clinics in the United States offering MoleSafe services. The LCRP works in

collaboration with local dermatologist to use MoleSafe as another surveillance tool

for melanoma survivors to enhance personalized medicine and positive survival

outcomes. MoleSafe uses new technology to help detect melanoma at an early,

and therefore treatable, stage. MoleSafe’s diagnosis can be more accurate than

a regular clinical inspection. Dana Coleman, the LCRP’s MoleSafe Melanographer

conducts MoleSafe digital imaging, skin cancer education, and discusses risk

factors and sun protection awareness with MoleSafe clients. During a MoleSafe

consult, Ms. Coleman conducts a comprehensive full-body assessment of an

individual’s skin, taking a combination of high resolution clinical and dermoscopy

images of skin and lesions. This provides an accurate record of the distribution

and locations of lesions, linked with individual diagnostic images, as well as an

overall skin condition – the MoleSafe melanogram. This digital melanogram is then

examined and diagnosed by a MoleSafe dermatologist certified in dermoscopy.

Ms. Coleman explains, “The overall goal is to detect abnormal melanocytic

lesions early on in order to enhance and coordinate care with the patient’s

dermatologist.”

A report, which is shared with the individual and their dermatologist, includes:

• Comments and recommendations for the treatment or monitoring of suspicious lesions;

• Printouts of lesions requiring treatment;

• A general melanoma risk rating; and

• A recommended MoleSafe follow-up program.

MoleSafe should be conducted annually to track changes to the skin.

“Melanoma is a huge problem, and it can be

deadly. But if you take care of it early, when

it’s local, it is highly treatable. We’re always

looking into technologies that will continue

to help us screen for melanoma, diagnose

early and treat responsibly. Mole Mapping is

just the beginning.”

–Howard Zaren, M.D.

Medical Director of St. Jpseph’s/Candler’s Nancy N.

and J. C. Lewis Cancer & Research Pavilion (LCRP)

Call 1.877.MOLESAFE (665.3723) to schedule an appointment. • For more information call 912-819-5704 or visit www.cancerpavilion.com.

What does a MoleSafe procedure involve?A MoleSafe procedure is conducted by a trained melanographer who examines you from head to toe, taking a combination of high resolution clinical and dermoscopy images of different sections of your body.

This gives an accurate record of the distribution and locations of lesions, linked with individual diagnostic images, as well as your overall skin condition – the MoleSafe melanogram. We will also assess your relevant risk factors and skin history, and teach you about your skin and what to look for between visits.

How is a MoleSafe melanogram analyzed?After your examination, your digital melanogram, including your records, is sent via a secure network to our MoleSafe central melanoma screening database and reviewed by MoleSafe’s international panel of melanoma dermatologists for assessment and diagnosis. A report is then prepared for you and your doctor, which includes:

• Comments and recommendations for the treatment or monitoring of suspicious lesions

• Printouts of lesions requiring treatment• A general melanoma risk rating• A recommended MoleSafe follow-up program

Your digital melanogram is then archived until your next visit.

Who benefi ts from a MoleSafe examination?Melanoma is most common in people of European descent, especially those with fair skin. The American Academy of Dermatologists recommends that people with many moles, odd-looking moles, or a personal or family history of melanoma have regular skin checks, and that is where MoleSafe can help.

You should also consider a MoleSafe examination if you have used sun beds, spend time in the sun or were sunburnt frequently when younger. One serious incidence of sunburn as a child can double melanoma risk in later life.

What steps can be taken to prevent melanoma? Exposure to sunlight is the leading cause of skin cancer. So always wear sunscreen of SPF30 or more, complemented by a hat and light cloth-ing, when you’re in the sun. If you have chil-dren, remember that it’s important to protect their skin too.

Skin cancer and melanoma are more treatable when caught early, so make sure you also examine your body regularly.

If you happen to spot changes in skin pigmenta-tion, non-healing scabs or sores, new moles or moles that change appearance, seek immedi-ate medical advice either from your physician or through the MoleSafe information line.

Frequently Asked Questions• What is involved? Digital dermoscopy imaging will make a

complete record of your skin and lesions -

a process that isn’t painful, invasive or harmful in any way. The MoleSafe procedure will require removal of your outer clothing, although you will be provided with a patient gown to wear throughout the procedure. The initial full-body procedure and consultation is typically one hour. A range of follow-up appointments are available for spot checks and full re-imaging.

• What happens to my MoleSafe records? MoleSafe data is stored on a secure central

database, which is used by all MoleSafe centers worldwide. That means your follow-up examination or spot checks can be performed in any of the states or countries we operate in. On special request, we can also provide your records on CD, if you wish to monitor your moles yourself or have your doctor review your melanogram.

• How often do I need to come? Ideally we’d like to see you a year after your

fi rst appointment. After your fi rst MoleSafe procedure, we’ll send you a reminder letter depending on your assessed risk.

• What if a lesion or mole becomes suspicious between appointments?

Once included in the MoleSafe melanoma screening database, you can have Spot Checks at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend that you take advantage of this service if you’re ever worried. Remember, early detection leaves nothing to chance.

A MoleSafe procedure is conducted by a

trained melanographer who examines you

from head to toe, taking a combination

of high resolution clinical and dermoscopy

images of different sections of your body.

What does a MoleSafe procedure involve?

This gives an accurate record of the

distribution and locations of lesions,

linked with individual diagnostic images,

as well as your overall skin condition – the

MoleSafe melanogram. We will also assess

your relevant risk factors and skin history,

and teach you about your skin and what

to look for between visits.

How is a MoleSafe melanogram analyzed?

After your examination, your digital melanogram, including your

records, is sent via a secure network to our MoleSafe central

melanoma screening database and reviewed by MoleSafe’s

international panel of melanoma dermatologists for assessment

and diagnosis. A report is then prepared for you and your doctor,

which includes:

• Comments and recommendations for the treatment or

monitoring of suspicious lesions

• Printouts of lesions requiring treatment

• A general melanoma risk rating

• A recommended MoleSafe follow-up program


Who benefi ts from a MoleSafe examination?

Melanoma is most common in people of European descent,

especially those with fair skin. The American Academy of

Dermatologists recommends that people with many moles,

odd-looking moles, or a personal or family history of melanoma

have regular skin checks, and that is where MoleSafe can help.

You should also consider a MoleSafe examination if you

have used sun beds, spend time in the sun or were sunburnt

frequently when younger. One serious incidence of sunburn as a

child can double melanoma risk in later life.

What steps can be taken to prevent melanoma?

Exposure to sunlight is the leading cause of skin cancer.

So always wear sunscreen of SPF30 or more, complemented

by a hat and light clothing, when you’re in the sun. If you have

children, remember that it’s important to protect their skin too.

Skin cancer and melanoma are more treatable when caught

early, so make sure you also examine your body regularly.

If you happen to spot changes in skin pigmentation,

non-healing scabs or sores, new moles or moles that change

appearance, seek immediate medical advice either from your

physician or through the MoleSafe information line.

early detection avoids the risk of melanoma

Every year more than 1 million Americans are affected by skin cancer and every hour an American will die from melanoma, the most lethal form of skin cancer.

Fortunately, melanoma is nearly always curable if detected at an early, and therefore treatable, stage. And that is where MoleSafe can help.

What is MoleSafe?

MoleSafe is a worldwide service that uses a new technology

developed in conjunction with leading experts in the field of

melanoma. MoleSafe can help detect melanoma at an early,

and therefore treatable, stage.

The process begins with a comprehensive full-body checkup to

assess your skin, using digital

imaging and dermoscopy scans

to produce a digital melanogram.

This melanogram is then

examined and diagnosed by a

MoleSafe dermatologist. Regular

follow-up examinations refer to

your stored melanogram and

allow comparisons of the scans

over time, detecting any problems

at an early stage.

MoleSafe’s diagnosis can be more

accurate than a regular clinical

inspection. This means there’s

less guesswork over time. We

will detect important sub-surface

features and changes in existing

moles as well as the appearance

of any new moles or lesions. MoleSafe’s accuracy can help in

reducing unnecessary excision by providing another opinion before

you have a lesion removed.

High-resolution image of mole.

Capturing an in-depth image in the dermoscopy mode.

Recording the images and data for dermatologist diagnosis.

Dermoscopy image of the same mole.

MMS0010 MoleSafe GP Brochure.indd 2 2/5/08 1:33:47 PM






















which includes:































What is MoleSafe?
















at an early stage.

















database, which is used by all MoleSafe centers worldwide. That means your follow-up examination or spot checks can be performed in any of the states or countries we operate in. On special request, we can also provide your records on CD, if you wish to monitor your moles yourself or have your doctor review your


fi rst appointment. After your fi rst MoleSafe procedure, we’ll send you a reminder letter

when caught early, so make sure you also examine

procedure, we’ll send you a reminder letter depending on your assessed risk.


Once included in the MoleSafe melanoma screening database, you can have Spot Checks at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend

at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend that you take advantage of this service if you’re ever worried. Remember, early detection leaves


nothing to chance.


that you take advantage of this service if you’re ever worried. Remember, early detection leaves that you take advantage of this service if you’re ever worried. Remember, early detection leaves ever worried. Remember, early detection leaves nothing to chance.



Once included in the MoleSafe melanoma

FOLD

FOLD

FOLD

FOLD


What does a MoleSafe procedure involve?A MoleSafe procedure is conducted by a trained melanographer who examines you from head to toe, taking a combination of high resolution clinical and dermoscopy images of different sections of your body.

This gives an accurate record of the distribution and locations of lesions, linked with individual diagnostic images, as well as your overall skin condition – the MoleSafe melanogram. We will also assess your relevant risk factors and skin history, and teach you about your skin and what to look for between visits.

How is a MoleSafe melanogram analyzed?After your examination, your digital melanogram, including your records, is sent via a secure network to our MoleSafe central melanoma screening database and reviewed by MoleSafe’s international panel of melanoma dermatologists for assessment and diagnosis. A report is then prepared for you and your doctor, which includes:

• Comments and recommendations for the treatment or monitoring of suspicious lesions

• Printouts of lesions requiring treatment• A general melanoma risk rating• A recommended MoleSafe follow-up program


Who benefi ts from a MoleSafe examination?Melanoma is most common in people of European descent, especially those with fair skin. The American Academy of Dermatologists recommends that people with many moles, odd-looking moles, or a personal or family history of melanoma have regular skin checks, and that is where MoleSafe can help.

You should also consider a MoleSafe examination if you have used sun beds, spend time in the sun or were sunburnt frequently when younger. One serious incidence of sunburn as a child can double melanoma risk in later life.

What steps can be taken to prevent melanoma? Exposure to sunlight is the leading cause of skin cancer. So always wear sunscreen of SPF30 or more, complemented by a hat and light cloth-ing, when you’re in the sun. If you have chil-dren, remember that it’s important to protect their skin too.

Skin cancer and melanoma are more treatable when caught early, so make sure you also examine your body regularly.

If you happen to spot changes in skin pigmenta-tion, non-healing scabs or sores, new moles or moles that change appearance, seek immedi-ate medical advice either from your physician or through the MoleSafe information line.

Frequently Asked Questions• What is involved? Digital dermoscopy imaging will make a

complete record of your skin and lesions -

a process that isn’t painful, invasive or harmful in any way. The MoleSafe procedure will require removal of your outer clothing, although you will be provided with a patient gown to wear throughout the procedure. The initial full-body procedure and consultation is typically one hour. A range of follow-up appointments are available for spot checks and full re-imaging.

• What happens to my MoleSafe records? MoleSafe data is stored on a secure central

database, which is used by all MoleSafe centers worldwide. That means your follow-up examination or spot checks can be performed in any of the states or countries we operate in. On special request, we can also provide your records on CD, if you wish to monitor your moles yourself or have your doctor review your melanogram.


fi rst appointment. After your fi rst MoleSafe procedure, we’ll send you a reminder letter depending on your assessed risk.


Once included in the MoleSafe melanoma screening database, you can have Spot Checks at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend that you take advantage of this service if you’re ever worried. Remember, early detection leaves nothing to chance.





















which includes:































What is MoleSafe?
















at an early stage.





































which includes:































What is MoleSafe?
















at an early stage.

















database, which is used by all MoleSafe centers worldwide. That means your follow-up examination or spot checks can be performed in any of the states or countries we operate in. On special request, we can also provide your records on CD, if you wish to monitor your moles yourself or have your doctor review your


fi rst appointment. After your fi rst MoleSafe procedure, we’ll send you a reminder letter

when caught early, so make sure you also examine



Once included in the MoleSafe melanoma screening database, you can have Spot Checks at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend

at any time between appointments. It’s important to have any new or changing moles assessed as soon as possible, so we recommend that you take advantage of this service if you’re ever worried. Remember, early detection leaves


nothing to chance.


that you take advantage of this service if you’re ever worried. Remember, early detection leaves that you take advantage of this service if you’re ever worried. Remember, early detection leaves ever worried. Remember, early detection leaves nothing to chance.



Once included in the MoleSafe melanoma

FOLD

FOLD

FOLD

FOLD



9

MoleSafe Screening Outcomes

MoleSafe Screening Outcomes2011-2012, LCRP Data

2011 2012

Number of MoleSafe Patients 33 78

Number of Lesions of Concern Identified 4 10

In 2011, MoleSafe screening identified lesions of concern that required further monitoring and diagnostic

evaluation by the patient’s dermatologist in 12.1% of individuals screened. In 2012, this remained fairly similar

with 12.8 % of the 78 individuals screened being identified with a lesion of concern. This collaboration

between the LCRP multi-disciplinary treatment and survivorship team with local dermatologists allowed

these individuals to access further diagnostic testing, and treatment when appropriate, in a timely manner.

225 Candler Drive Savannah, GA 31405 912-819-5704

MoleSafe a new form ofSKIN PROTECTION that leaves

nothing to chance

Every year more than 1 million Americans are affected by skin cancer

and every hour an American will die from melanoma, the most lethal form of skin cancer. Fortunately, melanoma is nearly always curable if detected at

an early, and therefore treatable, stage. And that is where MoleSafe can help.

Map out your body’s futureMelanoma is deadly. Many Americans, especially those of European descent, are at risk. Through new technology, MoleSafe greatly assists in the early detection and intervention of melanoma, leaving nothing to chance.

What is MoleSafe?MoleSafe is a worldwide service that uses a new technology developed in conjunction with leading experts in the fi eld of melanoma. MoleSafe can help detect melanoma at an early, and therefore treatable, stage.

The process begins with a comprehensive full-body checkup to assess your skin, using digital imaging and dermoscopy scans to produce a digital melanogram. This melanogram is then examined and diagnosed by a MoleSafe dermatologist. Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.

MoleSafe’s diagnosis can be more accurate than a regular clinical inspection. This means there’s less guesswork over time. We will detect important sub-surface features and changes in existing moles as well as the appearance of any new moles or lesions. MoleSafe’s accuracy can help in reducing unnecessary excision by providing another opinion before you have a lesion removed.





















which includes:































What is MoleSafe?
















at an early stage.





































which includes:































What is MoleSafe?
















at an early stage.
















Recording the images and data fordermatologist diagnosis.

at an early, and therefore


MoleSafe’s diagnosis can be more accurate than a

and diagnosed by a MoleSafe dermatologist. Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.


imaging and dermoscopy scans to produce a digital melanogram. This melanogram is then examined and diagnosed by a MoleSafe dermatologist. Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.

MoleSafe’s diagnosis can be more accurate than a regular clinical inspection. This means there’s less guesswork over time. We will detect important


imaging and dermoscopy scans to produce a digital melanogram. This melanogram is then examined

MoleSafe’s accuracy can help in reducing unnecessary well as the appearance of any new moles or lesions. MoleSafe’s accuracy can help in reducing unnecessary MoleSafe’s accuracy can help in reducing unnecessary excision by providing another opinion before you

Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.


have a lesion removed.

FOLD

FOLD

FOLD

FOLD

225 Candler Drive Savannah, GA 31405 912-819-5704

MoleSafe a new form ofSKIN PROTECTION that leaves

nothing to chance

Every year more than 1 million Americans are affected by skin cancer

and every hour an American will die from melanoma, the most lethal form of skin cancer. Fortunately, melanoma is nearly always curable if detected at

an early, and therefore treatable, stage. And that is where MoleSafe can help.

Map out your body’s futureMelanoma is deadly. Many Americans, especially those of European descent, are at risk. Through new technology, MoleSafe greatly assists in the early detection and intervention of melanoma, leaving nothing to chance.

What is MoleSafe?MoleSafe is a worldwide service that uses a new technology developed in conjunction with leading experts in the fi eld of melanoma. MoleSafe can help detect melanoma at an early, and therefore treatable, stage.























which includes:































What is MoleSafe?
















at an early stage.





































which includes:































What is MoleSafe?
















at an early stage.

















at an early, and therefore



and diagnosed by a MoleSafe dermatologist. Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.


imaging and dermoscopy scans to produce a digital melanogram. This melanogram is then examined and diagnosed by a MoleSafe dermatologist. Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.

MoleSafe’s diagnosis can be more accurate than a regular clinical inspection. This means there’s less guesswork over time. We will detect important


imaging and dermoscopy scans to produce a digital melanogram. This melanogram is then examined

MoleSafe’s accuracy can help in reducing unnecessary well as the appearance of any new moles or lesions. MoleSafe’s accuracy can help in reducing unnecessary MoleSafe’s accuracy can help in reducing unnecessary excision by providing another opinion before you

Regular follow-up examinations refer to your stored melanogram and allow comparisons of the scans over time, detecting any problems at an early stage.


have a lesion removed.

FOLD

FOLD

FOLD

FOLD

Capturing an in-depth image in the dermoscopy mode. Recording the images and data for dermatologist diagnosis.

10

Lewis Cancer & Research Pavilion Response

LCRP Skin Cancer Cases2011-2012, LCRP Cancer Registry Data

The LCRP is a regional destination for cancer care. In 2011, skin cancer was the sixth most commonly treated

cancer site at the LCRP. From 2011 to 2012, skin cancer cases treated at the LCRP increased 57% to 160

new cases. 2013 skin cancer cases have likewise continued to grow exponentially as the LCRP’s skin cancer

expertise is recognized regionally. In addition, the LCRP ensures all skin cancer patients have access to the

most technologically advanced treatment options that are supported by nationally recognized evidence-

based treatment guidelines through personalized medicine and access to clinical trials.

0

20

40

60

80

100 Non-analytic

Analytic

20122011

57

95

45

65Analytic cases: refers to patients who are either initially diagnosed at the LCRP or newly diagnosed elsewhere and are referred to LCRP for all or part of their initial treatment or decision not to treat.

Non-Analytic cases: refers to patients who are diagnosed and treated elsewhere, or diagnosed and treated prior to referral to the LCRP.

11

LCRP Analytic Skin Cancer Cases by Histology2012, LCRP Cancer Registry Data

HISTOLOGY NUMBER OF CASES PERCENT

Malignant melanoma 41 43.2%

Superficial spreading melanoma 22 23.2%

Melanoma in situ 8 8.4%

Nodular melanoma 6 6.3%

Merkel cell carcinoma 6 6.3%

Hutchinson’s melanotic freckle NOS 5 5.3%

Malignant melanoma in Hutchinson’s melanotic freckle 2 2.1%

Dermatofibrosarcoma 1 1.1%

Desmoplastic melanoma malignant 1 1.1%

Mycosis fungoides 1 1.1%

Superficial spreading melanoma in situ 1 1.1%

Spindle cell melanoma 1 1.1%

TOTAL 95 100%

With the continual development of the LCRP Pigmented Nevus Center, the LCRP multi-disciplinary treatment

team is increasingly treating rarer forms of aggressive skin cancer such as merkel cell carcinoma, skin

appendageal tumors, and sebaceous carcinoma.

Number of Patients by Age Range at Time of Skin Cancer Diagnosis (Analytic Cases)

2011-2012, LCRP Cancer Registry Data

30.5% of the individuals treated for skin cancer at the LCRP in 2011-2012 were age 70 or older. A significant

proportion - 38.2% - of individuals treated were ages 50 – 69 and 17.1% were individual ages 30 – 49.

0

5

10

15

20

25

30

35

20122011

70+60-6950-5940-4930-3920-29<200 1

34 3

8

4

11

7

18

12

21

28

32

12

Number of Patients by Stage and Sex at Time of Diagnosis (Analytic Cases)

2012, LCRP Cancer Registry Data

Significantly more men than women are treated at the LCRP for skin cancer. From 2011-2012, the LCRP

treated 104 men and 48 women. This corresponds to higher rates of skin cancer among men in Georgia and

nationally. In Georgia, men have a melanoma incidence rate of 28.9 per 100,000 while the incidence rate for

women is 16.7 per 100,000. 10 This means that it is more likely for men in Georgia to be diagnosed with skin

cancer than women.

Analytic Skin Cancer Cases by County of Residence at Time of Diagnosis2012, LCRP Cancer Registry Data

DIAGNOSIS COUNTY NUMBER OF CASES PERCENT

Chatham 54 57%

Beaufort, SC 10 11%

Bryan 9 9%

Effingham 6 6%

Bulloch 5 5%

Liberty 4 4%

Candler 1 1%

Houston 1 1%

Jasper, SC 1 1%

Glynn 1 1%

McIntosh 1 1%

Jeff Davis 1 1%

Hampton 1 1%

TOTAL 95 100%

The LCRP is responding to high skin cancer rates in Chatham, Beaufort, Bryan, and Effingham Counties. 83%

of the skin cancer cases treated at the LCRP in 2012 came from these four counties.

0

5

10

15

20

25

30

2012 Female

2012 Male

N/AStage UNKStage IVStage IIIStage IIStage IStage 0

87

65

32

4

10

1

12

4

30

12

13

Fishin’ for Jamie: Raising Funds for Melanoma Treatment and Research

The 2013 annual summer Fishin’ for Jamie golf and fishing tournament raised $15,000 for melanoma

treatment and research at the Lewis Cancer & Research Pavilion (LCRP). Members of Fishin’ for Jamie, Inc.

presented the check to Howard A. Zaren, Medical Director for the LCRP, and the staff in late November. Dr.

Zaren thanked the event organizers for their hard work and commented, “Not only does Fishin’ for Jamie

allow us to honor a Savannahian who died of melanoma, but it helps to raise awareness for the high risk of

melanoma in this region.”

Fishin’ for Jamie began in 2005 as a fishing tournament to raise funds for Jamie Fulcher, a young father

battling melanoma. Fulcher often had to travel outside Savannah for treatment because at that time there

were no local melanoma trials open for his stage of cancer. The funds raised from the original event helped

pay for Mr. Fulcher’s travel and other extra expenses. Before his death, Mr. Fulcher requested that the fishing

tournament continue. Mr. Fulcher’s wife, family, and friends started the non-profit organization that brings

the tournament back each year.

In 2012, a golf tournament was added to the fundraiser, making 2013 the second annual golf tournament.

Teams of four, including LCRP staff and physicians, played nine holes at Wilmington Island Golf Club. This

tournament, along with the growth of the fishing event, helped make this year’s donation the largest in the

fundraiser’s history.

Every dime raised from

this event goes directly to

melanoma treatment and

research. Thanks to the

growing number of melanoma

and other clinical trials offered

at the LCRP, individuals like

Mr. Fulcher no longer have to

travel outside of Savannah to

receive care. To learn more,

“like” the Fishin’ for Jamie

Facebook page.

14

Footnotes

1 Dunki-Jacobs E, Callendar G, McMasters K. Current Management of Melanoma, In Brief. Curr Probl Surg.

2013; 50:346-349.

2 Siegel R, Ma J, Zou Z, et al. Cancer Statistics, 2014. CA Cancer J Clin. 2014;64:9-29.

3 Dunki-Jacobs E, Callendar G, McMasters K. Current Management of Melanoma, In Brief. Curr Probl Surg.

2013; 50:346-349.

4 American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.


6 State Cancer Profiles, 2013.





SELECTED A NATIONAL CANCER INSTITUTE COMMUNITY CANCER CENTER PROGRAM.

nancy n. and j.c. lewis cancer & research pavilion skin ......the nancy n. and j.c. lewis cancer...

Documents